MSI-1256F

Squalamine lactate · Genaera Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MSI-1256F, covering 2007-11-28 to 2007-11-28. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration [Phase 2]

See pricing